Biocartis (Switzerland)
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.
Basic Information
- Category: business
- Website: https://www.biocartis.com
Documented Facts
- Phone: +3215632600 (No linked source recorded for this statement.)
- Email: info@biocartis.com (No linked source recorded for this statement.)
Evidence and Sources
- Biocartis (Switzerland) — Official Site (official)
- Biocartis (Switzerland) on facebook (social)
- Biocartis (Switzerland) on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Biocartis (Switzerland).
- Canonical profile: https://brandsource.ai/brands/biocartis-switzerland
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/biocartis-switzerland/json-ld
- Citation profile API: https://brandsource.ai/api/brands/biocartis-switzerland/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Partial
- Profile completeness: Source-backed profile (83/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus on oncology.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 2 structured facts available for extraction.
Known data gaps
- Profile enrichment is incomplete
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.